New procedure codes in Belgian Nomenclature came into force in April 2019

13

May 2019

The health benefit Nomenclature of the Belgian National Institute for Health and Disability Insurance (INAMI/RIZIV) includes the benefits (with specific hospital and ambulatory codes) that are reimbursed by the compulsory health care insurance, wholly or partially. The Nomenclature and its changes are published in the Belgian Official Gazette.

On March 7, 2019, the Nomenclature was updated. The update brought changes in chapter V of Nomenclature, regarding the creation of new codes, deletion, and modification of existing codes.

The changes of the following articles of the Nomenclature will come into force since April 1, 2019:

Key changes in the clinical biology (24) article:

  • Fourty-three new codes regarding biochemistry, microbiology, hematology, immunohematology have been introduced
  • Conditions for reimbursement of these codes were added
  • Three (3) codes were delisted
  • Minor modifications of existing codes were made

Key changes in the clinical biology (24bis) article:

  • Seven (7) new codes regarding molecular biology tests have been introduced
  • Conditions for reimbursement of these codes were added

Key changes in the ophthalmology (14) article:

  • Minor modifications of existing conditions of reimbursement of “Intravitreal injection performed under conditions strict asepsis” (248334-248345) were made

Key changes in the plastic surgery (14c) article:

  • Modifications of existing codes
  • Modifications of existing conditions for reimbursement

Key changes in the anesthesiology (12) article:

  • Modifications of existing codes
  • New code (202871-202882) for treatment of acute pain was added

See full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

27

Jan 2023

On January 09, 2023, the National Institute for Health and Disability Insurance (INAMI-RIZIV) published 2023 tariffs for the “low variability care” (APR-DRG) system. APR-DRG logic for 2023 is not published as of January 27, so no information about its changes or new DRGs is available.

Read more

26

Jan 2023

The updated German Uniform Evaluation Standard (EBM) catalog came into force on January 1, 2023. The EBM catalog (Einheitlicher Bewertungsmaßstab) regulates the reimbursement of services in the public outpatient sector in Germany and is updated once a quarter (four times a year). Among other changes, a new code for "zanadio" health app for follow-up and evaluation was introduced in the catalog.

Read more

25

Jan 2023

On December 31, 2022, the Decree defining the reimbursement of medical telemonitoring activities via the new framework was published in the Official Journal of the French Republic. The Decree determines the methods of evaluation of digital solutions, registration for reimbursement, modification of the registration conditions, removal and invoicing of medical telemonitoring activities, as well as the conditions for setting the reimbursement packages.

Read more

24

Jan 2023

In December 2022, NHS England launched a consultation on the preliminary 2023/25 NHS Payment Scheme, which is set for two years and will replace the National Tariff Payment System from April 2023. Two new cardiovascular categories (antibacterial envelope, mitral valve repair and replacement devices) are proposed for inclusion in the 2023/24 High Cost Device List (will be updated and reissued for 2024/25). The deadline for comments submission is January 27, 2023.

Read more

23

Jan 2023

On December 26, 2022, three more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by sickness funds.

Read more